Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review
Open Access
- 5 May 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 22 (1) , 393-409
Abstract
Current safety data from Phase 3 clinical trials have concluded that apart from transient local and systemic reactions, no safety concerns were identified for the Moderna COVID-19 vaccine (mRNA-127...Keywords
This publication has 32 references indexed in Scilit:
- A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccineVaccine, 2021
- Venous thromboembolism in cancer patients: a population-based cohort studyBlood, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsNew England Journal of Medicine, 2020
- An overview of COVID-19Journal of Zhejiang University-SCIENCE B, 2020
- Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysisHuman Reproduction Update, 2020
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticalsAdvanced Drug Delivery Reviews, 2020
- Effects of Ageing on the Immune System: Infants to ElderlyScandinavian Journal of Immunology, 2016
- Gender differences in myocarditis: a nationwide study in FinlandEuropean Heart Journal, 2013
- REVIEW ARTICLE: The Immune System in Pregnancy: A Unique ComplexityAmerican Journal of Reproductive Immunology, 2010